封面
市场调查报告书
商品编码
1683394

全球智慧绷带市场 - 2025 至 2033 年

Global Smart Bandages Market - 2025-2033

出版日期: | 出版商: DataM Intelligence | 英文 159 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球智慧绷带市场规模达到 8.2378 亿美元,预计到 2033 年将达到 32.273 亿美元,在 2025-2033 年预测期内的复合年增长率为 14.6%。

智慧绷带是一种先进的伤口护理敷料,具有感测器、药物传输系统和即时监测功能。它们追踪伤口状况,如湿度水平、酸碱平衡和细菌感染,为医疗保健专业人员提供宝贵的资料。一些智慧绷带可以将药物直接输送到伤口部位,促进更快恢復并减少换药次数。

这些敷料对慢性伤口、烧伤和术后护理特别有益,可最大限度地减少併发症并改善患者的治疗效果。随着石墨烯和水凝胶等材料的进步,智慧绷带变得更加灵活和高效。

市场动态:

驱动因素与约束因素

慢性伤口盛行率上升

全球智慧绷带市场的发展受到慢性伤口增加的推动,尤其是影响数百万名糖尿病、肥胖和循环系统疾病患者的伤口。传统的伤口护理方法难以控制这些情况,因此需要智慧绷带等先进的解决方案。这些敷料具有即时监测、湿度调节和药物传输功能,可改善伤口癒合效果。随着慢性伤口发病率的增加,智慧绷带的采用预计将增长,从而增强患者护理并降低医疗成本。

例如,根据 NCBI 的一项研究,每年有 866 名出现新慢性伤口的患者就诊,平均每年 54 例。慢性溃疡的发生率为每1000人口1.2人,盛行率为每1000人口3.3人。大多数患者为男性(57.2%),平均年龄为41.7岁±20.6岁。创伤后伤口是主要原因,年龄与病因呈正相关。镰状细胞和静脉伤口主要发生在腿部,随着年龄的增长,慢性伤口的发生也随之增加。

监管挑战

全球智慧绷带市场面临挑战,因为 FDA 和 EMA 设定了严格的监管审批流程,要求医疗设备满足严格的安全性和有效性标准。这个复杂的过程可能会导致产品发布延迟、增加进入市场的时间和投资,并使不同地区的製造商面临全球商业化的挑战,从而限制市场成长。

目录

第一章:市场介绍和范围

  • 报告目标
  • 报告范围和定义
  • 报告范围

第 2 章:高阶主管见解与关键要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分类的片段
  • 技术片段
  • 按应用程式截取的程式码片段
  • 按配销通路分类的片段
  • 按地区分类的片段

第 3 章:动态

  • 影响因素
    • 驱动程式
      • 慢性伤口盛行率上升
      • 穿戴式科技的进步
    • 限制
      • 监管挑战
      • 技术限制
    • 机会
      • 新兴市场扩张
    • 影响分析

第四章:战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析:最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 5 章:智慧绷带市场(依产品类型)

  • 石墨烯绷带
  • 合成纤维绷带

第 6 章:智慧绷带市场(按技术)

  • 无线感测器
  • 柔性电子

第 7 章:智慧绷带市场(按应用)

  • 烧伤引起的慢性皮肤创伤
  • 糖尿病引起的慢性皮肤创伤
  • 其他原因导致的慢性皮肤创伤

第 8 章:智慧绷带市场(依配销通路)

  • 零售药局
  • 医院药房
  • 其他的

第 9 章:智慧绷带市场,按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章:竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的关键发展
  • 公司基准化分析

第 11 章:公司简介

  • Grapheal
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • 3M Company
  • The Wound Pros, Inc
  • Baxter International Inc
  • Coloplast A/S
  • SURVIVAL

第 12 章:假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章:附录

简介目录
Product Code: MD9334

The global smart bandages market reached US$ 823.78 million in 2024 and is expected to reach US$ 3227.30 million by 2033, growing at a CAGR of 14.6% during the forecast period 2025-2033.

Smart bandages are advanced wound care dressings with sensors, drug delivery systems, and real-time monitoring capabilities. They track wound conditions like moisture levels, pH balance, and bacterial infections, providing valuable data to healthcare professionals. Some smart bandages can deliver medications directly to the wound site, promoting faster recovery and reducing dressing changes.

These dressings are particularly beneficial for chronic wounds, burns, and post-surgical care, minimizing complications and improving patient outcomes. With advancements in materials like graphene and hydrogel, smart bandages are becoming more flexible and efficient.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Chronic Wounds

The global smart bandages market is driven by the rise in chronic wounds, particularly those affecting millions of people with diabetes, obesity, and circulatory disorders. Traditional wound care methods struggle to manage these conditions, leading to a demand for advanced solutions like smart bandages. These dressings offer real-time monitoring, moisture regulation, and drug delivery capabilities, improving wound healing outcomes. As chronic wound incidence increases, smart bandage adoption is expected to grow, enhancing patient care and reducing healthcare costs.

For instance, according to an NCBI study, 866 patients with new chronic wounds were seen annually, with an average of 54 cases per year. Chronic ulcers develop at a rate of 1.2/1000 population, with a prevalence of 3.3/1000. Most patients were males (57.2%), with a mean age of 41.7 years +- 20.6. Post-traumatic wounds were the leading cause, with age positively correlated with aetiology. Sickle cell and venous wounds were predominantly on the legs, with an increasing age correlated with chronic wound occurrence.

Regulatory Challenges

The global smart bandage market faces challenges due to the stringent regulatory approval process set by the FDA and EMA, which requires medical devices to meet strict safety and efficacy standards. This complex process can cause delays in product launches, increase market entry time and investment, and make global commercialization challenging for manufacturers across different regions, limiting market growth.

Segment Analysis

The global smart bandages market is segmented based on product type, technology, application, distribution channel, and region.

Product Type:

The graphene-based bandages from the application segment are expected to dominate the smart bandages market with the highest market share

Graphene-based bandages are transforming the global smart bandages market by offering superior wound healing capabilities. Their exceptional electrical conductivity allows real-time wound monitoring, enabling early detection of infections. Graphene's high mechanical strength and flexibility ensure durability and patient comfort. Its natural antimicrobial properties reduce infection risk, making it beneficial for chronic wounds, burns, and diabetic ulcers. These bandages can also be integrated with drug delivery systems for controlled medication release. As demand for tech-enabled wound care solutions increases, graphene-based bandages are expected to drive significant advancements.

Geographical Analysis

North America is expected to hold a significant position in the Smart Bandages market with the highest market share

The North American smart bandages market is fueled by chronic wounds, such as diabetic ulcers and pressure sores, due to the aging population and diabetes cases. The region's strong healthcare infrastructure and reimbursement policies support advanced wound care solutions. Technological advancements, such as sensors and real-time monitoring, enhance the effectiveness of smart bandages. Leading medical device companies and substantial research investments fuel market growth. Growing awareness among healthcare professionals and patients about smart bandage benefits and increasing home healthcare adoption contribute to market expansion.

For instance, in June 2024, Chronic wounds, including diabetic ulcers and pressure injuries, have a poorer five-year survival rate than other serious diseases and cost an estimated $28 billion annually in the U.S. Treating wounds is expensive, with researchers from the Keck School of Medicine of USC and the California Institute of Technology developing advanced technologies to revolutionize wound care. These technologies include smart bandages that automatically respond to changing wound conditions, providing continuous data on healing and potential complications and enabling real-time delivery of medications or treatments.

Competitive Landscape

The major global players in the smart bandages market include Grapheal, 3M Company, The Wound Pros, Inc, Baxter International Inc, Coloplast A/S, SURVIVAL and among others.

Key Developments

  • In June 2024, the Keck School of Medicine of USC and the California Institute of Technology developed advanced technologies, including smart bandages, to revolutionize wound care by automatically sensing and responding to changing conditions, providing continuous data on healing and potential complications, and potentially delivering drugs or treatments in real time.
  • In May 2024, Researchers from the University of Southampton are developing smart bandages that enable remote monitoring and use LED lights to sterilize wounds as they heal, using ultraviolet-C light for treatment.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global smart bandages market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by Distribution Channel
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Chronic Wounds
      • 3.1.1.2. Advancements in Wearable Technologies
    • 3.1.2. Restraints
      • 3.1.2.1. Regulatory Challenges
      • 3.1.2.2. Technical Limitations
    • 3.1.3. Opportunity
      • 3.1.3.1. Emerging Markets Expansion
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Smart Bandages Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Graphene-Based Bandages*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Synthetic Fiber Bandages

6. Smart Bandages Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Wireless Sensors*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Flexible Electronic

7. Smart Bandages Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Chronic Skin Wounds from Burns*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Chronic Skin Wounds from Diabetes
  • 7.4. Chronic Skin Wounds from Other Causes

8. Smart Bandages Market, By Distribution Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 8.1.2. Market Attractiveness Index, By Distribution Channel
  • 8.2. Retail Pharmacies*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hospital Pharmacies
  • 8.4. Others

9. Smart Bandages Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Grapheal*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. 3M Company
  • 11.3. The Wound Pros, Inc
  • 11.4. Baxter International Inc
  • 11.5. Coloplast A/S
  • 11.6. SURVIVAL

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us